So what to make of Dermira’s (NASDAQ:DERM) latest success? On Friday, the dermatology drug maker announced that the FDA has approved the company’s hyperhidrosis …
It’s a big day for Dermira (NASDAQ:DERM). This morning, the FDA green-lighted the drug maker’s Qbrexza (formerly DRM04), making it the first FDA-approved, once-daily, …
Shares of Dermira Inc (NASDAQ:DERM) plunged hard Monday, after the drug maker announced negative Phase 3 data for its acne drug, DRM01, thus leading …
Some investors might love biotech stocks for their lottery ticket-like returns when a company strikes medical gold. A lottery ticket, however, costs only …
